Clee Medical is proud to celebrate its first anniversary, marking a year of rapid growth, clinical progress, and technological achievement on its mission to enable safer, more precise, and more effective neurosurgery.
Since its founding as a spin-out from the Wyss Center, Clee Medical has evolved from a research concept into a leading force in real-time intraoperative imaging and AI-guided navigation. Over the past year, the team has reached several major milestones from prestigious awards to clinical validation and strategic collaborations.
In our first year, we:
- Won the »venture» 2025 competition, standing out among a record 396 Swiss startups.
- Secured an Innosuisse grant with the Bern University of Applied Sciences (BFH) to accelerate development of its AI-driven imaging platform.
- Formed a partnership with the Swiss Foundation for Innovation and Training in Surgery (SFITS) to advance clinical adoption and surgical training.
- Ranked #56 in the Swiss Top 100 Startups, reflecting growing national recognition for innovation and impact.
- Exhibited at the European Society for Stereotactic and Functional Neurosurgery (ESSFN), showcasing the Neuro Access platform to the global neurosurgical community.
Most importantly, we have real life cases in the operating room. Our device has already been used in 11 neurosurgical procedures, demonstrating its potential to provide surgeons with unprecedented, real-time visualization of brain anatomy and vasculature.
As Clee Medical enters its second year, we continue to expand our partnerships and prepare for broader clinical deployment of the Neuro Access platform to forge the path toward a new era of precision-guided neurosurgery.